Additionally, accumulated anti-nAChR antibodies have been shown to modulate muscular IL-6 production altering mTOR signaling which may be responsible for MG-associated muscle fatigue (Maurer et al., 2015). Here, CHRNA4 is linked to myasthenia gravis.